Do gait parameters improve after botulinum toxin injections in post stroke patients? A prospective study.


Journal

Toxicon : official journal of the International Society on Toxinology
ISSN: 1879-3150
Titre abrégé: Toxicon
Pays: England
ID NLM: 1307333

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 10 02 2021
revised: 16 07 2021
accepted: 04 08 2021
pubmed: 14 8 2021
medline: 8 9 2021
entrez: 13 8 2021
Statut: ppublish

Résumé

The intramuscular injection of botulinum toxin is one of the most efficient ways to treat localized spasticity in patients suffering from Central Nervous System lesions like stroke, cerebral palsy and multiple sclerosis. The gait analysis based on kinetics and kinematics is a recognized way of measurement of the effect of intramuscular injection of botulinum toxin in spastic patients suffering from chronic stroke. The aim of this study is to provide evidence of the beneficial effect of botulinum toxin on characteristics of gait pattern on patients suffering from chronic stroke. So, thirteen patients with spasticity due to chronic stroke were included in the protocol and were treated by botulinum toxin injections in the lower extremity. All patients were evaluated before the injection as well as one month after the botulinum injection on a foot pressure sensitive walkway with a power plate and by the readings of seven inertial measurements units which recorded spatio-temporal specific parameters during walking, and the spasticity was measured according to modified Ashworth Scale. While all spatio-temporal parameters of motion analysis and balance improved for most of the patients after botulinum toxin injection, only one parameter, the normal to hemiplegic step length, reached statistical significant improvement (p < 0.03). Moreover the modified Ashworth score was statistically improved post injection (p < 0.001). In conclusion the use of botulinum toxin injections is beneficial in post stroke patients as this is depicted in gait parameters improvement which accompanies the spasticity reduction.

Identifiants

pubmed: 34384786
pii: S0041-0101(21)00212-9
doi: 10.1016/j.toxicon.2021.08.001
pii:
doi:

Substances chimiques

Neuromuscular Agents 0
Botulinum Toxins, Type A EC 3.4.24.69

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

189-197

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Dimitrios N Varvarousis (DN)

Department of Physical Medicine and Rehabilitation, University of Ioannina, S. Niarchos Ave, Ioannina, 45110, Greece. Electronic address: dvarvarous@uoi.gr.

Dimitris Dimopoulos (D)

Department of Physical Medicine and Rehabilitation, University of Ioannina, S. Niarchos Ave, Ioannina, 45110, Greece. Electronic address: ddimop@uoi.gr.

George I Vasileiadis (GI)

Department of Physical Medicine and Rehabilitation, University of Ioannina, S. Niarchos Ave, Ioannina, 45110, Greece. Electronic address: givasileiadis@yahoo.co.uk.

Ioannis Manolis (I)

Department of Physical Medicine and Rehabilitation, University of Ioannina, S. Niarchos Ave, Ioannina, 45110, Greece. Electronic address: y7manolis@yahoo.gr.

Avraam Ploumis (A)

Department of Physical Medicine and Rehabilitation, University of Ioannina, S. Niarchos Ave, Ioannina, 45110, Greece. Electronic address: aploumis@uoi.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH